Abbreviation |
Definition |
APCs |
Antigen-presenting cells |
cDNA |
Complementary DNA |
CDDP |
Cis-diamminedichloridplatinum, cisplatin |
CI |
Confidence intervals |
CT |
Computed tomogaphy |
Ct |
Cycle threshold |
CTLs |
Cytotoxic T lymphocytes |
ECOG |
Eastern Cooperative Oncology Group |
EDTA |
Ethylenediamenetetraacetic acid |
Et-OH |
Ethanol |
GALNT7 |
N-acetylgalactosaninyltransferase 7 |
GEM |
Gemcitabine |
HR |
Hazard ratio |
MATN2 |
Matrilin 2 |
miRNAs |
microRNAs |
MRI |
Magnetic resonance imaging |
M-CSF |
Macrophage colony-stimulating factor |
non-SqCC |
non-Squamous |
OS |
Overall survival |
PD |
Progression disease |
PEM |
pemetrexed |
PFS |
Progression free survival |
PR |
Partial response |
PS |
Performance status |
RT-qPCR |
Real-time quantative polymerase chain reaction |
SD |
Stable disease |
SqCC |
Squamous |
STAT3 |
Signal transducer and activator of transcription 3 |
TAMs |
Tumor associated macrophages |
TME |
Tumor microenvironment |
TXT |
Taxotere |